{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:23:59Z","timestamp":1755224639351,"version":"3.43.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009228","name":"Region \u00d6rebro County","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009228","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003509","name":"\u00d6rebro University","doi-asserted-by":"publisher","award":["OLL-985238","OLL-960784"],"award-info":[{"award-number":["OLL-985238","OLL-960784"]}],"id":[{"id":"10.13039\/501100003509","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>For unidentified reasons, possibly due to increased immune surveillance, patients with collagenous colitis (CC) and lymphocytic colitis (LC), both forms of microscopic colitis (MC), have lower risk of colorectal cancer than controls and ulcerative colitis (UC) patients. Levels of secreted and cell-bound mediators in MC patients with active disease and in histological remission (HR) compared to UC patients and controls were investigated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Median fluorescence intensity of 54 analytes in colonic biopsies from patients with active CC (n\u2005=\u200521), LC (n\u2005=\u200511), and UC (n\u2005=\u200519); CC-HR (n\u2005=\u20056), LC-HR (n\u2005=\u20059), UC in remission (n\u2005=\u200519), non-diarrhea controls (n\u2005=\u200548), and diarrhea controls (n\u2005=\u200525) was measured using Luminex.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Granzyme B and CCL5 levels were higher in active CC than in UC, whereas CCL4 and CD163 levels were similar in CC and UC, and both groups had higher levels of matrix metalloproteinase (MMP)-1, MMP-3, and tumor necrosis factor receptor II than both control groups. APRIL, BAFF, BCMA, CCL20, CXCL8, chitinase 3-like 1, pentraxin-3, Fas, and IL-33 were higher in UC than MC. Increases in 4-1BB and perforin in MC compared to controls were lower than in UC. Levels of gp130 and IL-6R\u03b1 were decreased in MC but increased in UC compared to controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Microscopic colitis patients exhibit increased levels of several analytes, including some associated with CD8+ T lymphocytes, suggesting a different pathogenesis of MC compared to UC. Higher levels of MMP-1 and MMP-3 in CC than LC indicate separate disease entities.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ibd\/izaf064","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T15:37:36Z","timestamp":1744299456000},"page":"2231-2243","source":"Crossref","is-referenced-by-count":0,"title":["Increased Colonic Levels of CD8+ Cytotoxic T lymphocyte-Associated Mediators in Patients With Microscopic Colitis"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3591-4948","authenticated-orcid":false,"given":"Alexandra","family":"Lushnikova","sequence":"first","affiliation":[{"name":"School of Medical Sciences, \u00d6rebro University , \u00d6rebro ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Wickbom","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, \u00d6rebro University Hospital, Faculty of Medicine and Health, \u00d6rebro University , \u00d6rebro ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Bohr","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, \u00d6rebro University Hospital, Faculty of Medicine and Health, \u00d6rebro University , \u00d6rebro ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Kruse","sequence":"additional","affiliation":[{"name":"School of Medical Sciences, \u00d6rebro University , \u00d6rebro ,","place":["Sweden"]},{"name":"Department of Clinical Research Laboratory, Faculty of Medicine and Health, \u00d6rebro University , \u00d6rebro ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Wir\u00e9n","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, \u00d6rebro University , \u00d6rebro ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Hultgren H\u00f6rnquist","sequence":"additional","affiliation":[{"name":"School of Medical Sciences, \u00d6rebro University , \u00d6rebro ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"2025081217443248900_CIT0001","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.humpath.2022.06.027","article-title":"Microscopic colitis: lymphocytic colitis, collagenous colitis, and beyond","volume":"132","author":"Yuan","year":"2023","journal-title":"Hum Pathol."},{"issue":"12","key":"2025081217443248900_CIT0002","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1080\/00365521.2023.2248536","article-title":"Regional differences in the incidence of lymphocytic and collagenous colitis over time","volume":"58","author":"Larsson","year":"2023","journal-title":"Scand J Gastroenterol."},{"issue":"10","key":"2025081217443248900_CIT0003","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41577-021-00534-x","article-title":"The inflammatory pathogenesis of colorectal cancer","volume":"21","author":"Schmitt","year":"2021","journal-title":"Nat Rev Immunol."},{"issue":"1","key":"2025081217443248900_CIT0004","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/00054725-199902000-00006","article-title":"Cancer risk in collagenous colitis","volume":"5","author":"Chan","year":"1999","journal-title":"Inflamm Bowel Dis."},{"issue":"4","key":"2025081217443248900_CIT0005","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1093\/ecco-jcc\/jjaa207","article-title":"Disease activity patterns, mortality, and colorectal cancer risk in microscopic colitis: a Danish Nationwide Cohort Study, 2001 to 2016","volume":"15","author":"Weimers","year":"2021","journal-title":"J Crohns Colitis."},{"issue":"2","key":"2025081217443248900_CIT0006","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/ecco-jcc\/jjaa156","article-title":"Microscopic colitis and risk of cancer\u2014AA population-based cohort study","volume":"15","author":"Bergman","year":"2021","journal-title":"J Crohns Colitis."},{"issue":"1","key":"2025081217443248900_CIT0007","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10620-011-1852-2","article-title":"Decreased colorectal cancer and adenoma risk in patients with microscopic colitis","volume":"57","author":"Yen","year":"2012","journal-title":"Dig Dis Sci."},{"issue":"2","key":"2025081217443248900_CIT0008","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8+ T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br J Cancer."},{"issue":"9","key":"2025081217443248900_CIT0009","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.crohns.2012.08.014","article-title":"Microscopic colitis patients have increased proportions of Ki67+ proliferating and CD45RO+ active\/memory CD8+ and CD4+8+ mucosal T cells","volume":"7","author":"Kumawat","year":"2013","journal-title":"J Crohns Colitis."},{"issue":"10","key":"2025081217443248900_CIT0010","doi-asserted-by":"publisher","first-page":"e434","DOI":"10.1016\/j.crohns.2013.02.007","article-title":"Immunohistochemical characterization of lymphocytes in microscopic colitis","volume":"7","author":"G\u00f6ranzon","year":"2013","journal-title":"J Crohns Colitis."},{"issue":"4","key":"2025081217443248900_CIT0011","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/ecco-jcc\/jjx160","article-title":"Intestinal T cell profiling in inflammatory bowel disease: linking T cell subsets to disease activity and disease course","volume":"12","author":"Smids","year":"2018","journal-title":"J Crohns Colitis."},{"issue":"2","key":"2025081217443248900_CIT0012","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"J Crohns Colitis."},{"key":"2025081217443248900_CIT0013","doi-asserted-by":"publisher","first-page":"727412","DOI":"10.3389\/fmed.2021.727412","article-title":"Patients with microscopic colitis have altered levels of inhibitory and stimulatory biomarkers in colon biopsies and sera compared","volume":"8","author":"Lushnikova","year":"2021","journal-title":"Front Med"},{"key":"2025081217443248900_CIT0014","doi-asserted-by":"publisher","first-page":"26996","DOI":"10.1038\/srep26996","article-title":"The statistical value of raw fluorescence signal in Luminex xMAP based multiplex immunoassays","volume":"6","author":"Breen","year":"2016","journal-title":"Sci Rep."},{"issue":"2","key":"2025081217443248900_CIT0015","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cyto.2014.10.030","article-title":"Bead-based multiplex immuno-assays for cytokines, chemokines, growth factors and other analytes: median fluorescence intensities versus their derived absolute concentration values for statistical analysis","volume":"71","author":"Breen","year":"2015","journal-title":"Cytokine."},{"year":"2023","author":"R Core Team","key":"2025081217443248900_CIT0016"},{"key":"2025081217443248900_CIT0017","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-21706-2","volume-title":"Modern Applied Statistics with S","author":"Venables","year":"2002","edition":"4"},{"issue":"1","key":"2025081217443248900_CIT0018","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"2025081217443248900_CIT0019","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.cca.2020.07.036","article-title":"Reference interval of monocyte distribution width (MDW) in healthy blood donors","volume":"510","author":"Agnello","year":"2020","journal-title":"Clin Chim Acta."},{"issue":"2","key":"2025081217443248900_CIT0020","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/s1074-7613(04)00027-5","article-title":"Human CD8+ T cells store RANTES in a unique secretory compartment and release it rapidly after TcR stimulation","volume":"20","author":"Catalfamo","year":"2004","journal-title":"Immunity."},{"key":"2025081217443248900_CIT0021","doi-asserted-by":"publisher","first-page":"132458","DOI":"10.1155\/2015\/132458","article-title":"Enhanced levels of chemokines and their receptors in the colon of microscopic colitis patients indicate mixed immune cell recruitment","volume":"2015","author":"G\u00fcnaltay","year":"2015","journal-title":"Mediators Inflamm."},{"issue":"2","key":"2025081217443248900_CIT0022","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0002-9440(10)65145-0","article-title":"Fibrogenesis and fibrolysis in collagenous colitis","volume":"155","author":"G\u00fcnther","year":"1999","journal-title":"Am J Pathol."},{"issue":"6","key":"2025081217443248900_CIT0023","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/ecco-jcc\/jjy224","article-title":"Expression profiling of inflammatory and immunological genes in collagenous colitis","volume":"13","author":"Liu","year":"2019","journal-title":"J Crohns Colitis."},{"key":"2025081217443248900_CIT0024","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3389\/fimmu.2018.00583","article-title":"The significance of tumor necrosis factor receptor type II in CD8+ regulatory T cells and CD8+ effector T cells","volume":"9","author":"Ye","year":"2018","journal-title":"Front Immunol."},{"issue":"3","key":"2025081217443248900_CIT0025","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00384-004-0639-8","article-title":"Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways","volume":"20","author":"Souza","year":"2005","journal-title":"Int J Colorectal Dis."},{"issue":"2","key":"2025081217443248900_CIT0026","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1053\/gast.2002.34784","article-title":"Mechanisms of diarrhea in collagenous colitis","volume":"123","author":"B\u00fcrgel","year":"2002","journal-title":"Gastroenterology."},{"issue":"10","key":"2025081217443248900_CIT0027","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1007\/s00535-017-1309-2","article-title":"Epithelial barrier dysfunction in lymphocytic colitis through cytokine-dependent internalization of claudin-5 and -8","volume":"52","author":"Barmeyer","year":"2017","journal-title":"J Gastroenterol."},{"issue":"3-4","key":"2025081217443248900_CIT0028","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molimm.2013.03.007","article-title":"Microscopic colitis patients demonstrate a mixed Th17\/Tc17 and Th1\/Tc1 mucosal cytokine profile","volume":"55","author":"Kumawat","year":"2013","journal-title":"Mol Immunol."},{"issue":"4","key":"2025081217443248900_CIT0029","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrg3185","article-title":"Insights into the regulation of protein abundance from proteomic and transcriptomic analyses","volume":"13","author":"Vogel","year":"2012","journal-title":"Nat Rev Genet."},{"issue":"7","key":"2025081217443248900_CIT0030","doi-asserted-by":"publisher","first-page":"102846","DOI":"10.1016\/j.autrev.2021.102846","article-title":"CCR6-CCL20 axis as a therapeutic target for autoimmune diseases","volume":"20","author":"Meitei","year":"2021","journal-title":"Autoimmun Rev."},{"issue":"1","key":"2025081217443248900_CIT0031","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat Rev Immunol."},{"key":"2025081217443248900_CIT0032","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.cytogfr.2022.07.005","article-title":"The involvement of TH17 cells in the pathogenesis of IBD","volume":"69","author":"Jiang","year":"2023","journal-title":"Cytokine Growth Factor Rev."},{"issue":"6","key":"2025081217443248900_CIT0033","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.crohns.2012.07.022","article-title":"Cytokine mucosal expression in ulcerative colitis, the relationship between cytokine release and disease activity","volume":"7","author":"Pearl","year":"2013","journal-title":"J Crohns Colitis."},{"issue":"5","key":"2025081217443248900_CIT0034","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00428-014-1543-4","article-title":"The histopathological approach to inflammatory bowel disease: a practice guide","volume":"464","author":"Langner","year":"2014","journal-title":"Virchows Arch."},{"issue":"1","key":"2025081217443248900_CIT0035","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/2050640620951905","article-title":"European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations","volume":"9","author":"Miehlke","year":"2021","journal-title":"United Eur Gastroenterol J"},{"issue":"7","key":"2025081217443248900_CIT0036","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1002\/ibd.21188","article-title":"Budesonide treatment of patients with collagenous colitis restores normal eosinophil and T-cell activity in the colon","volume":"16","author":"Wagner","year":"2010","journal-title":"Inflamm Bowel Dis."},{"issue":"13","key":"2025081217443248900_CIT0037","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.3390\/jcm12134339","article-title":"Circulating profiles of serum proguanylin, S100A12 protein and Pentraxin 3 as diagnostic markers of ulcerative colitis","volume":"12","author":"Ka\u0142u\u017cna","year":"2023","journal-title":"J Clin Med"},{"issue":"4","key":"2025081217443248900_CIT0038","doi-asserted-by":"publisher","first-page":"e1177","DOI":"10.7759\/cureus.1177","article-title":"Crohn\u2019s disease and ulcerative colitis show unique cytokine profiles","volume":"9","author":"Nemeth","year":"2017","journal-title":"Cureus"},{"issue":"7","key":"2025081217443248900_CIT0039","doi-asserted-by":"publisher","first-page":"e69839","DOI":"10.1371\/journal.pone.0069839","article-title":"Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease","volume":"8","author":"Franz\u00e8","year":"2013","journal-title":"PLoS One."},{"issue":"1","key":"2025081217443248900_CIT0040","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1084\/jem.20031330","article-title":"BCMA is essential for the survival of long-lived bone marrow plasma cells","volume":"199","author":"O\u2019Connor","year":"2004","journal-title":"J Exp Med."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izaf064\/62907039\/izaf064.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/8\/2231\/62907039\/izaf064.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/8\/2231\/62907039\/izaf064.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T21:44:41Z","timestamp":1755035081000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/31\/8\/2231\/8110523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,4,10]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izaf064","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"type":"print","value":"1078-0998"},{"type":"electronic","value":"1536-4844"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,4,10]]}}}